论文部分内容阅读
上半年,市场出现深幅调整,医药板块也跟着出现了较大幅度的调整,随着半年报的逐渐披露,医药公司业绩的快速增长将重新恢复投资者的信心,一些业绩增长快速而确定、股价又出现深幅调整的公司将带来较好的投资机会。
In the first half of the year, the market witnessed a deep readjustment and the pharmaceutical sector also witnessed a more substantial readjustment. With the gradual disclosure of the semi-annual report, the rapid growth of pharmaceutical companies’ performance will regain the confidence of investors and some of the performance growth will be rapidly confirmed. Companies with deep correction of share prices will bring better investment opportunities.